Follow
Daniel Y. Kim
Daniel Y. Kim
Harvard Medical School
Verified email at hms.harvard.edu
Title
Cited by
Cited by
Year
Evolution of the Pseudomonas aeruginosa quorum-sensing hierarchy
M Kostylev, DY Kim, NE Smalley, I Salukhe, EP Greenberg, AA Dandekar
Proceedings of the National Academy of Sciences 116 (14), 7027-7032, 2019
2342019
CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells
K Petri, W Zhang, J Ma, A Schmidts, H Lee, JE Horng, DY Kim, IC Kurt, ...
Nature biotechnology 40 (2), 189-193, 2022
1432022
Maternal consumption of ultra-processed foods and subsequent risk of offspring overweight or obesity: results from three prospective cohort studies
Y Wang, K Wang, M Du, N Khandpur, SL Rossato, CH Lo, H VanEvery, ...
BMJ 379, 2022
552022
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito
WT Garrood, N Kranjc, K Petri, DY Kim, JA Guo, AM Hammond, ...
Proceedings of the National Academy of Sciences 118 (22), e2004838117, 2021
372021
The mental health burden of racial and ethnic minorities during the COVID-19 pandemic
LH Nguyen, A Anyane-Yeboa, K Klaser, J Merino, DA Drew, W Ma, ...
PloS one 17 (8), e0271661, 2022
332022
Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects
K Petri, DY Kim, KE Sasaki, MC Canver, X Wang, H Shah, H Lee, ...
bioRxiv, 2021
222021
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation
E Konstantinidis, A Molisak, F Perrin, L Streubel-Gallasch, S Fayad, ...
Molecular Therapy-Nucleic Acids 28, 450-461, 2022
212022
Racial Differences in Genomic Profiles of Breast Cancer
N Goel*, DY Kim*, JA Guo, D Zhao, BA Mahal, M Alshalalfa
JAMA Network Open 5 (3), e220573-e220573, 2022
182022
Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection
JA Guo, HI Hoffman, SG Shroff, P Chen, PG Hwang, DY Kim, DW Kim, ...
Clinical cancer research 27 (10), 2807-2815, 2021
152021
Pan-Cancer Survival Classification With Clinicopathological and Targeted Gene Expression Features
D Zhao*, DY Kim*, P Chen*, P Yu, S Ho, SW Cheng, C Zhao, JA Guo, ...
Cancer Informatics 20, 11769351211035137, 2021
62021
Disease flare in patients with dermatomyositis following COVID-19 vaccination
CX Pan, N Goldman, DY Kim, R Rowley, M Schaefer, AH LaChance, ...
Journal of the American Academy of Dermatology 87 (6), 1373-1374, 2022
42022
Cutaneous immune‐related adverse events from immune checkpoint inhibitor therapy: Moving beyond “maculopapular rash”
BS Allais, CJ Fay, DY Kim, YR Semenov, NR LeBoeuf
Immunological Reviews 318 (1), 22-36, 2023
32023
Nicotinamide for Skin-Cancer Chemoprevention in Transplantation
N Trepanowski, DY Kim, RI Hartman
The New England journal of medicine 388 (26), 2493-2494, 2023
32023
Trends in hair, skin, and nails supplement use: Data from the National Health and Nutrition Examination Survey 2011-2020
N Trepanowski, KJ Moore, DY Kim, RI Hartman
Journal of the American Academy of Dermatology 89 (1), 161-163, 2023
22023
DNA repair and immune checkpoint blockade response
JA Guo*, M Alshalalfa*, DY Kim*, HI Hoffman, C Shiau, J Su, WL Hwang, ...
Cancer Genetics, 2022
22022
Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells
K Petri, W Zhang, J Ma, A Schmidts, H Lee, JE Horng, DY Kim, IC Kurt, ...
Nature Biotechnology 40 (2), 273-273, 2022
22022
Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade using Tissue Cyclic Immunofluorescence: A Pilot Study
Z Maliga, DY Kim, ATN Bui, JR Lin, AK Dewan, S Jadeja, GF Murphy, ...
The Journal of investigative dermatology, S0022-202X (24) 00107-6, 2024
12024
Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation
CX Pan, WC Lau, DY Kim, CB Lau, R Rowley, R Kanwar, NR LeBoeuf, ...
Journal of the American Academy of Dermatology 89 (6), 1264-1268, 2023
12023
Incidence of In Situ and Invasive Cutaneous Melanomas During the COVID-19 Pandemic in the US
DY Kim, RI Hartman
JAMA dermatology 159 (10), 1141-1145, 2023
12023
Differences in thickness-specific incidence of cutaneous melanoma by county type in the United States, 2010 to 2019
DY Kim, MA Marchetti, RI Hartman
Journal of the American Academy of Dermatology 89 (3), 597-600, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20